phase readout
saveNCT02652767: Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: GenSight Biologics. Phase: PHASE3. Conditions: Optic, Atrophy, Hereditary, Leber
view source ↗
comments(0)
5-min edit window · permanent after that